News

benzinga_article
2026.01.08 16:57
RenovoRx shares are trading higher. The company announced that it will present a new clinical data abstract from a pharmacokinetic and pharmacodynamic sub‑study of its ongoing Phase III TIGeR‑PaC clinical trial at the ASCO GI.
Source: benzinga_article The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2026 Longbridge｜Disclaimer